Code intelligence

0075U reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code 0075U.

Elevated code risk

Signal breakdown

12 shown · 12 total in platform

Risk: Elevated
0

Critical

0%

3

High

25%

9

Routine

75%

0

Low

0%

New this month

+1

alerts added in last 30 days

Effective soon

no upcoming deadlines

LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS

Policy LCD-L36021 · Clinical Laboratory

High

New MolDX policy effective in 2025 may alter billing processes.

LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian

Policy LCD-L36256 · Clinical Laboratory

High

New molecular diagnostics policy may impact billing processes.

LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian

Policy LCD-L35160 · Clinical Laboratory

High

New MolDX guidelines may alter MDT billing processes.

LCD L38337: MolDX: Pharmacogenomics Testing — Noridian

Policy LCD-L38337 · Clinical Laboratory

Routine

New coverage for pharmacogenomics testing effective 10/02/2025

LCD L38394: MolDX: Pharmacogenomics Testing — CGS

Policy LCD-L38394 · Clinical Laboratory

Routine

New pharmacogenomics testing affects billing from 2025.

LCD L38335: MolDX: Pharmacogenomics Testing — Noridian

Policy LCD-L38335 · Clinical Laboratory

Routine

Prepare for changes in pharmacogenomics testing billing.

LCD L38294: MolDX: Pharmacogenomics Testing — Palmetto GBA

Policy LCD-L38294 · Clinical Laboratory

Routine

New LCD for Pharmacogenomics Testing effective 10/02/2025

LCD L38351: MolDX: Repeat Germline Testing — Noridian

Policy LCD-L38351 · Oncology

Routine

New guidelines for repeat germline testing could impact reimbursements.

LCD L38680: MolDx: Molecular Testing for Solid Organ Allograft Rejection — WPS

Policy LCD-L38680 · Clinical Laboratory

Routine

WPS LCD L38680 for allograft rejection molecular testing now retired.

LCD L38435: MolDX: Pharmacogenomics Testing — WPS

Policy LCD-L38435 · Clinical Laboratory

Routine

New billing guidelines for Pharmacogenomics Testing effective 2025.

LCD L38288: MolDX: Repeat Germline Testing — CGS

Policy LCD-L38288 · Oncology

Routine

New LCD may impact repeat germline testing reimbursements.

LCD L38353: MolDX: Repeat Germline Testing — Noridian

Policy LCD-L38353 · Clinical Laboratory

Routine

New LCD on germline testing impacts billing practices.

Audit documentation

Building an audit file that includes 0075U?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription